跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24 条关于
“QH104A”
全部
24
临床试验
10
药物
6
机构
0
资讯
8
上个月
T-MAXIMUM's Universal CAR-T MT027 to Debut Brain Metastasis Data at WCLC 2026 as Intracranial Tumors Emerge as Solid Tumor CAR-T's Second Battlefield
去年
Tharimmune's TH104 Receives Positive EMA Feedback for Pruritus in Primary Biliary Cholangitis
去年
EMA Endorses Tharimmune's TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis
去年
Tharimmune's TH104 Advances to Phase 2 for Pruritus in Primary Biliary Cholangitis
去年
Tharimmune Advances TH104 as National Security Solution Against Weaponized Fentanyl, Secures $5.47M Funding
去年
Tharimmune Appoints New CEO and Board Members to Advance Opioid Antagonist TH104 Development
去年
FDA Clears Expedited Pathway for Tharimmune's TH104 Opioid Defense Drug Without Additional Clinical Trials
去年
Delhi High Court Rules Against Roche in Pertuzumab Patent Disclosure Case, Clarifies Section 104A Requirements for Biologics